Background: Alport syndrome (AS) is a genetic disease characterized by progressive glomerulonephritis with a high life-time risk for end-stage renal disease (ESRD), sensorineural hearing loss and ocular abnormalities. So far, a lot of mutations were reported in , and genes, which are related to AS.

Methods: Whole-exome sequencing in combination with AS-related genes filtering strategy was applied to investigate a Chinese AS family. We also employed Sanger sequencing to confirm the family co-segregation. In addition, we also summed up a long-term follow-up data from 2003 to 2016.

Results: In this study, we have detected a novel insertion mutation (c.348_349insTCCGG/p.G117Sfs×40) of , which may lead to a truncated protein in the proband. Sanger sequencing confirmed that this novel mutation was co-segregated with all the family members. The long-term follow-up data showed that the progress of chronic kidney disease become more and more serious in the proband.

Conclusions: A novel mutation (c.348_349insTCCGG/p.G117Sfs×40) of was identified in this study. In addition, approximately 15 years long-term follow-up data was provided in this paper. Our study not only expands the spectrum of mutations, but also analysis the progress of AS and fills the knowledge about course and potential further complications and health risks of AS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965389PMC

Publication Analysis

Top Keywords

long-term follow-up
16
novel mutation
12
follow-up data
12
alport syndrome
8
sanger sequencing
8
mutation c348_349instccgg/pg117sfs×40
8
long-term
4
follow-up alport
4
syndrome patient
4
novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!